Radiosensitization effects of berberine on human breast cancer cells

International Journal of Molecular Medicine

Volumn 30, Issue 5, 2012, Pages 1166-1172

  Wang, Jing ^a,b   Liu, Qiao ^c   Yang, Qifeng ^a  

^a SHANDONG UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Berberine; Breast cancer; DNA repair; Radiosensitization

Indexed keywords

BERBERINE; DIMETHYL SULFOXIDE; HISTONE H2AX; KU ANTIGEN; RAD51 PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL SURVIVAL; CHEMORADIOTHERAPY; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IONIZING RADIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION; RADIATION DOSE; RADIOSENSITIVITY; RADIOSENSITIZATION; WESTERN BLOTTING; X RAY;

ANTIGENS, NUCLEAR; BERBERINE; BREAST NEOPLASMS; CELL SURVIVAL; DNA BREAKS, DOUBLE-STRANDED; DNA-BINDING PROTEINS; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; HISTONES; HUMANS; MCF-7 CELLS; RAD51 RECOMBINASE; RADIATION-SENSITIZING AGENTS;

EID: 84866623599     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1095     Document Type: Article

References (34)

1. Yip CH, Smith RA, Anderson BO, et al: Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 113: 2244-2256, 2008.
2. Igene H: Global health inequalities and breast cancer: an impending public health problem for developing countries. Breast J 14: 428-434, 2008.
3. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
4. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717, 2005.
5. Jemal A, Center MM, DeSantis C and Ward EM: Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19: 1893-1907, 2010.
6. Yamamoto K, Takase H, Abe K, Saito Y and Suzuki A: Pharmacological studies on antidiarrheal effects of a preparation containing berberine and geranii herba. Nihon Yakurigaku Zasshi 101: 169-175, 1993 (In Japanese). (Pubitemid 23126118)
7. Huang WM, Wu ZD and Gan YQ: Effects of berberine on ischemic ventricular arrhythmia. Zhonghua Xin Xue Guan Bing Za Zhi 17: 300-301, 319, 1989 (In Chinese).
8. Takase H, Yamamoto K, Ito K and Yumioka E: Pharmacological studies on antidiarrheal effects of berberine and geranii herba. Nihon Yakurigaku Zasshi 102: 101-112, 1993 (In Japanese). (Pubitemid 23278238)
9. Sanders MM, Liu AA, Li TK, et al: Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells. Biochem Pharmacol 56: 1157-1166, 1998. (Pubitemid 28511238)
10. Lin CC, Yang JS, Chen JT, et al: Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 27: 3371-3378, 2007.
11. Hwang JM, Kuo HC, Tseng TH, Liu JY and Chu CY: Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells. Arch Toxicol 80: 62-73, 2006.
12. Lin JP, Yang JS, Lee JH, Hsieh WT and Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 12: 21-28, 2006.
13. Mantena SK, Sharma SD and Katiyar SK: Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 5: 296-308, 2006.
14. Liu Z, Liu Q, Xu B, et al: Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat Res 662: 75-83, 2009.
15. Tang J, Feng Y, Tsao S, Wang N, Curtain R and Wang Y: Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126: 5-17, 2009.
16. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC and Ho TY: Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol Res 56: 193-201, 2007. (Pubitemid 47321202)
17. Thirupurasundari CJ, Padmini R and Devaraj SN: Effect of berberine on the antioxidant status, ultrastructural modifications and protein bound carbohydrates in azoxymethane-induced colon cancer in rats. Chem Biol Interact 177: 190-195, 2009.
18. Kim S, Choi JH, Kim JB, et al: Berberine suppresses TNF-alpha-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13: 2975-2985, 2008.
19. Peng PL, Kuo WH, Tseng HC and Chou FP: Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 70: 529-542, 2008.
20. Liu Q, Jiang H, Liu Z, et al: Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One 6: e23427, 2011.
21. Liu Y, Yu H, Zhang C, et al: Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur J Cancer 44: 2425-2432, 2008.
22. Li GH, Zhang YP, Tang JL, et al: Effects of berberine against radiation-induced intestinal injury in mice. Int J Radiat Oncol Biol Phys 77: 1536-1544, 2010.
23. Franken NA, Rodermond HM, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319, 2006.
24. Li X, Kong X, Huo Q, et al: Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci 102: 1151-1157, 2011.
25. Bernhard EJ, Maity A, Muschel RJ and McKenna WG: Effects of ionizing radiation on cell cycle progression. A review. Radiat Environ Biophys 34: 79-83, 1995.
26. Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942, 2004. (Pubitemid 38834285)
27. Xu B, Kim ST, Lim DS and Kastan MB: Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell Biol 22: 1049-1059, 2002. (Pubitemid 34094842)
28. Busse PM, Bose SK, Jones RW and Tolmach LJ: The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res 76: 292-307, 1978. (Pubitemid 9037669)
29. Mao Z, Jiang Y, Liu X, Seluanov A and Gorbunova V: DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. Neoplasia 11: 683-691, 2009.
30. Helleday T, Lo J, van Gent DC and Engelward BP: DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 6: 923-935, 2007. (Pubitemid 46880473)
31. Collis SJ, Tighe A, Scott SD, Roberts SA, Hendry JH and Margison GP: Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res 29: 1534-1538, 2001. (Pubitemid 32288501)
32. Ohnishi T, Taki T, Hiraga S, Arita N and Morita T: In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. Biochem Biophys Res Commun 245: 319-324, 1998. (Pubitemid 28418498)
33. Russell JS, Brady K, Burgan WE, et al: Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res 63: 7377-7383, 2003. (Pubitemid 37413479)
34. Tsai MS, Kuo YH, Chiu YF, Su YC and Lin YW: Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells. J Pharmacol Exp Ther 335: 830-840, 2010.